340 related articles for article (PubMed ID: 31664624)
1. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
3. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Signature of Endometrial Cancer.
Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
[TBL] [Abstract][Full Text] [Related]
5. A comparative evaluation of the generalised predictive ability of eight machine learning algorithms across ten clinical metabolomics data sets for binary classification.
Mendez KM; Reinke SN; Broadhurst DI
Metabolomics; 2019 Nov; 15(12):150. PubMed ID: 31728648
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence and the analysis of multi-platform metabolomics data for the detection of intrauterine growth restriction.
Bahado-Singh RO; Yilmaz A; Bisgin H; Turkoglu O; Kumar P; Sherman E; Mrazik A; Odibo A; Graham SF
PLoS One; 2019; 14(4):e0214121. PubMed ID: 30998683
[TBL] [Abstract][Full Text] [Related]
8. A tutorial review: Metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding.
Gromski PS; Muhamadali H; Ellis DI; Xu Y; Correa E; Turner ML; Goodacre R
Anal Chim Acta; 2015 Jun; 879():10-23. PubMed ID: 26002472
[TBL] [Abstract][Full Text] [Related]
9. Potential application of body fluids autofluorescence in the non-invasive diagnosis of endometrial cancer.
Švecová M; Fiedlerová K; Mareková M; Dubayová K
Klin Onkol; 2024; 38(2):102-109. PubMed ID: 38697818
[TBL] [Abstract][Full Text] [Related]
10. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
11. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
Shen X; Wang C; Liang N; Liu Z; Li X; Zhu ZJ; Merriman TR; Dalbeth N; Terkeltaub R; Li C; Yin H
Arthritis Rheumatol; 2021 Sep; 73(9):1738-1748. PubMed ID: 33760368
[TBL] [Abstract][Full Text] [Related]
12. [Early stage diagnosis of endometrial cancer based on near infrared spectroscopy and support vector machine].
Zhai W; Xiang YH; Dai YM; Zhang JJ; Zhang ZY
Guang Pu Xue Yu Guang Pu Fen Xi; 2011 Apr; 31(4):932-6. PubMed ID: 21714232
[TBL] [Abstract][Full Text] [Related]
13. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
14. Grading of endometrial cancer using
Skorupa A; Poński M; Ciszek M; Cichoń B; Klimek M; Witek A; Pakuło S; Boguszewicz Ł; Sokół M
Sci Rep; 2021 Sep; 11(1):18160. PubMed ID: 34518615
[TBL] [Abstract][Full Text] [Related]
15. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
16. Predictive Modeling for Metabolomics Data.
Ghosh T; Zhang W; Ghosh D; Kechris K
Methods Mol Biol; 2020; 2104():313-336. PubMed ID: 31953824
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics in endometrial cancer diagnosis: A systematic review.
Raffone A; Troisi J; Boccia D; Travaglino A; Capuano G; Insabato L; Mollo A; Guida M; Zullo F
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1135-1146. PubMed ID: 32180221
[TBL] [Abstract][Full Text] [Related]
18. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
19. A preliminary study on early postmortem submersion interval (PMSI) estimation and cause-of-death discrimination based on nontargeted metabolomics and machine learning algorithms.
Zhang FY; Wang LL; Dong WW; Zhang M; Tash D; Li XJ; Du SK; Yuan HM; Zhao R; Guan DW
Int J Legal Med; 2022 May; 136(3):941-954. PubMed ID: 35099605
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
